1-4 of 4
Chia-Wei Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inequalities in Treatment Utilization Among Older Medicare Beneficiaries with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Induction Therapy

Amer M. Zeidan, Yanqing Xu, Tatyana A. Kapustyan, Kaylee Miu, Cheng Chen, Rajesh Kamalakar, Chia-Wei Lin, Esprit Ma, Melissa Montez, Zheng Wu, Tracy Yee, Haiyan Sun, Andrew Rava, Sonia Kim, Scott F Huntington
Journal: Blood
Blood (2024) 144 (Supplement 1): 3795.
https://doi.org/10.1182/blood-2024-200213
Published: 2024
Journal Articles

Cost-Effectiveness of Emicizumab Vs Efanesoctocog Alfa, Standard Half Life (SHL) and Other Extended Half Life (EHL) FVIII Products for Prophylaxis in People with Severe Hemophilia a without Inhibitors

Randall Curtis, Marquita Decker-Palmer, Michele R Wilson, Cheryl L McDade, Chia-Wei Lin, Chris Wallick, Richard H Ko
Journal: Blood
Blood (2023) 142 (Supplement 1): 5053.
https://doi.org/10.1182/blood-2023-181062
Published: 2023
Journal Articles

Cost-Effectiveness of Emicizumab for Prophylaxis in People with Severe Hemophilia A without Inhibitors

Marquita Decker-Palmer, Chia-Wei Lin, Michele Wilson, Cheryl McDade, Komal Bawa, Stacey Kowal, Arliene Ravelo, Elaine Yu, Richard H. Ko
Journal: Blood
Blood (2022) 140 (Supplement 1): 13041–13042.
https://doi.org/10.1182/blood-2022-162276
Published: 2022
Journal Articles

Patient-Reported Outcomes Among Adults with Hemophilia A on Prophylactic Treatment

Janet Chupka, Marquita Decker-Palmer, Chia-Wei Lin, Ashley Martin, Kushal Modi, Dawn Bates, Karen Thomson
Journal: Blood
Blood (2022) 140 (Supplement 1): 10893–10894.
https://doi.org/10.1182/blood-2022-159064
Published: 2022